The Migration Medication Situation: Pharmacotherapy Consideration in Refugee Populations

<p>Jennifer M. Nelson, Pharm.D., outlines Center for Disease Control and Prevention (CDC) guidelines for initial care of refugee populations, recognizes unique disease states, genetics, and cultural considerations for the Afghan refugee population, and identifies treatment for unique disease states in the Afghan refugee population. </p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>